Millbrae, California
United States
19
2026-03-19
The entities that hold a legal rights for patent applications filed by inventor Wang Yingcai:
Yingcai Wang from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#2 | 2024-09-12Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#3 | 2023-02-16Compounds that inhibit MCL-1 protein
#4 | 2022-06-02Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#5 | 2021-07-29Compounds that inhibit MCL-1 protein
#6 | 2021-06-17Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#7 | 2019-02-28Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#8 | 2017-05-25Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#9 | 2016-05-19Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#10 | 2014-10-23Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#11 | 2014-01-09PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
#12 | 2011-12-29Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#13 | 2011-08-04Spirocyclic GPR40 modulators
#14 | 2010-11-25Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
#15 | 2010-06-03BENZO-FUSED COMPOUNDS FOR USE IN TREATING METABOLIC DISORDERS
#16 | 2010-03-25Heterocyclic GPR40 modulators
#17 | 2009-11-05Phenyl acetic acid derivatives
#18 | 2009-11-05Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
#19 | 2009-05-28Substituted biphenyl GPR40 modulators
606432 ⎘